Prestige Wealth Management Group LLC Ironwood Pharmaceuticals Inc Transaction History
Prestige Wealth Management Group LLC
- $442 Million
- Q2 2024
Shares
2 transactions
Others Institutions Holding IRWD
# of Institutions
246Shares Held
171MCall Options Held
11.2MPut Options Held
28.5K-
Black Rock Inc. New York, NY22.9MShares$96.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$91.2 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$69.3 Million18.04% of portfolio
-
State Street Corp Boston, MA9.24MShares$39.1 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA8.91MShares$37.7 Million0.15% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $648M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...